357 related articles for article (PubMed ID: 31534535)
1. Chronic Model of Inflammatory Bowel Disease in IL-10
Wang H; Vilches-Moure JG; Cherkaoui S; Tardy I; Alleaume C; Bettinger T; Lutz A; Paulmurugan R
Theranostics; 2019; 9(21):6031-6046. PubMed ID: 31534535
[No Abstract] [Full Text] [Related]
2. Contrast Enhanced Ultrasound Molecular Imaging of Spontaneous Chronic Inflammatory Bowel Disease in an Interleukin-2 Receptor α
Wang H; Vilches-Moure JG; Bettinger T; Cherkaoui S; Lutz A; Paulmurugan R
Nanomaterials (Basel); 2022 Jan; 12(2):. PubMed ID: 35055297
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Inflammation in an Acute on Chronic Model of Inflammatory Bowel Disease with Ultrasound Molecular Imaging.
Machtaler S; Knieling F; Luong R; Tian L; Willmann JK
Theranostics; 2015; 5(11):1175-86. PubMed ID: 26379784
[TBL] [Abstract][Full Text] [Related]
4. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model.
Wang H; Machtaler S; Bettinger T; Lutz AM; Luong R; Bussat P; Gambhir SS; Tranquart F; Tian L; Willmann JK
Radiology; 2013 Jun; 267(3):818-29. PubMed ID: 23371306
[TBL] [Abstract][Full Text] [Related]
6. Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasound.
Brückner M; Heidemann J; Nowacki TM; Cordes F; Stypmann J; Lenz P; Gohar F; Lügering A; Bettenworth D
World J Gastroenterol; 2017 Apr; 23(16):2899-2911. PubMed ID: 28522908
[TBL] [Abstract][Full Text] [Related]
7. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice.
De Fazio L; Cavazza E; Spisni E; Strillacci A; Centanni M; Candela M; Praticò C; Campieri M; Ricci C; Valerii MC
World J Gastroenterol; 2014 Feb; 20(8):2051-61. PubMed ID: 24587679
[TBL] [Abstract][Full Text] [Related]
9. Methods of Inducing Inflammatory Bowel Disease in Mice.
Bang B; Lichtenberger LM
Curr Protoc Pharmacol; 2016 Mar; 72():5.58.1-5.58.42. PubMed ID: 26995548
[TBL] [Abstract][Full Text] [Related]
10. Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD).
Gadaleta RM; Garcia-Irigoyen O; Moschetta A
Curr Protoc Mouse Biol; 2017 Mar; 7(1):13-28. PubMed ID: 28252200
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model.
Seoane-Viaño I; Gómez-Lado N; Lázare-Iglesias H; Barreiro-de Acosta M; Silva-Rodríguez J; Luzardo-Álvarez A; Herranz M; Otero-Espinar F; Antúnez-López JR; Lamas MJ; Aguiar P; Fernández-Ferreiro A; Ruibal Á
Int J Pharm; 2018 Oct; 549(1-2):335-342. PubMed ID: 30081226
[TBL] [Abstract][Full Text] [Related]
12. PPARGC1A affects inflammatory responses in photodynamic therapy (PDT)-treated inflammatory bowel disease (IBD).
Liu C; Jiang Y; Liu G; Guo Z; Jin Q; Long D; Zhou W; Qian K; Zhao H; Liu K
Biochem Pharmacol; 2022 Aug; 202():115119. PubMed ID: 35667414
[TBL] [Abstract][Full Text] [Related]
13. The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis.
Cardoso A; Gil Castro A; Martins AC; Carriche GM; Murigneux V; Castro I; Cumano A; Vieira P; Saraiva M
Front Immunol; 2018; 9():400. PubMed ID: 29545807
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.
Ohkawara T; Nishihira J; Takeda H; Hige S; Kato M; Sugiyama T; Iwanaga T; Nakamura H; Mizue Y; Asaka M
Gastroenterology; 2002 Jul; 123(1):256-70. PubMed ID: 12105854
[TBL] [Abstract][Full Text] [Related]
15. High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.
Holgersen K; Kutlu B; Fox B; Serikawa K; Lord J; Hansen AK; Holm TL
J Crohns Colitis; 2015 Jun; 9(6):492-506. PubMed ID: 25795566
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human MFG-E8 ameliorates colon damage in DSS- and TNBS-induced colitis in mice.
Zhang Y; Brenner M; Yang WL; Wang P
Lab Invest; 2015 May; 95(5):480-90. PubMed ID: 25751740
[TBL] [Abstract][Full Text] [Related]
17. PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner.
Wei F; Zhang Y; Jian J; Mundra JJ; Tian Q; Lin J; Lafaille JJ; Tang W; Zhao W; Yu X; Liu CJ
Sci Rep; 2014 Nov; 4():7023. PubMed ID: 25387791
[TBL] [Abstract][Full Text] [Related]
18. Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model.
Bennink RJ; van Montfrans C; de Jonge WJ; de Bruin K; van Deventer SJ; te Velde AA
Nucl Med Biol; 2004 Jan; 31(1):93-101. PubMed ID: 14741574
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production.
Kozicky LK; Menzies SC; Hotte N; Madsen KL; Sly LM
Eur J Immunol; 2019 Aug; 49(8):1251-1268. PubMed ID: 31054259
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease.
te Velde AA; de Kort F; Sterrenburg E; Pronk I; ten Kate FJ; Hommes DW; van Deventer SJ
Inflamm Bowel Dis; 2007 Mar; 13(3):325-30. PubMed ID: 17206675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
